Analyst Ratings For NYSE:ZYME – Zymeworks (NYSE:ZYME)
Today, Canaccord Genuity reiterated its Buy rating on NYSE:ZYME – Zymeworks (NYSE:ZYME) with a price target of $18.00 ➝ $21.00.
Some recent analyst ratings include
- 5/16/2018-Canaccord Genuity Reiterated Rating of Buy.
- 5/14/2018-Ladenburg Thalmann initiated coverage with a Buy rating.
- 5/11/2018-Barclays Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
- 3/19/2018-Raymond James initiated coverage with a Outperform ➝ Outperform rating.
- 9/30/2017-Cormark Reiterated Rating of Buy.
- 5/23/2017-Citigroup initiated coverage with a Buy ➝ Buy rating.
- 5/23/2017-Wells Fargo initiated coverage with a Outperform ➝ Outperform rating.
Recent Trading Activity for NYSE:ZYME – Zymeworks (NYSE:ZYME)
Shares of NYSE:ZYME – Zymeworks closed the previous trading session at 17.01 up +0.44 2.66% with shares trading hands.